TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.50
-0.02 (-0.36%)
At close: Apr 1, 2025, 4:00 PM
5.54
+0.04 (0.76%)
After-hours: Apr 1, 2025, 4:01 PM EDT

TriSalus Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
--59.04-47.19-28.85-31.83
Depreciation & Amortization
-0.70.40.460.32
Other Amortization
---1.745.97
Loss (Gain) From Sale of Assets
-0.230.31-00.04
Stock-Based Compensation
-1.40.370.110.02
Other Operating Activities
-5.9211.53.979
Change in Accounts Receivable
--1.98-0.2-0.74-0.42
Change in Inventory
--1.07-0.18-0.730.76
Change in Accounts Payable
-2.845.253.18-0.03
Change in Other Net Operating Assets
-0.95-2.57-1.840.59
Operating Cash Flow
--50.05-32.31-22.7-15.58
Capital Expenditures
--0.59-0.66-1.1-0.55
Cash Acquisitions
--1-1-1-
Sale (Purchase) of Intangibles
--0.53-0.13-0.16-0.16
Other Investing Activities
-----9
Investing Cash Flow
--2.12-1.79-2.26-9.7
Long-Term Debt Issued
---0.0525.48
Long-Term Debt Repaid
--0.09-0.13-1.35-0.7
Net Debt Issued (Repaid)
--0.09-0.13-1.324.78
Issuance of Common Stock
-0.180.090.050.01
Other Financing Activities
-35.72---
Financing Cash Flow
-54.6313.4650.7724.81
Net Cash Flow
-2.46-20.6425.81-0.48
Free Cash Flow
--50.63-32.97-23.79-16.13
Free Cash Flow Margin
--273.53%-265.91%-283.23%-296.74%
Free Cash Flow Per Share
--5.39-106.48-2.68-2.10
Cash Interest Paid
---0.020.05
Cash Income Tax Paid
-0.010.010-
Levered Free Cash Flow
--51.81-0.15-24.49-
Unlevered Free Cash Flow
--51.8-0.15-25.13-
Change in Net Working Capital
7.3818.94-22.649.43-
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q